Review




Structured Review

Decibel Therapeutics aav strc gene transfer
Preclinical therapeutic pipeline for inner ear hearing disorders.
Aav Strc Gene Transfer, supplied by Decibel Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav strc gene transfer/product/Decibel Therapeutics
Average 90 stars, based on 1 article reviews
aav strc gene transfer - by Bioz Stars, 2026-02
90/100 stars

Images

1) Product Images from "Recent Therapeutic Progress and Future Perspectives for the Treatment of Hearing Loss"

Article Title: Recent Therapeutic Progress and Future Perspectives for the Treatment of Hearing Loss

Journal: Biomedicines

doi: 10.3390/biomedicines11123347

Preclinical therapeutic pipeline for inner ear hearing disorders.
Figure Legend Snippet: Preclinical therapeutic pipeline for inner ear hearing disorders.

Techniques Used: Formulation, Inhibition



Similar Products

90
Decibel Therapeutics aav strc gene transfer
Preclinical therapeutic pipeline for inner ear hearing disorders.
Aav Strc Gene Transfer, supplied by Decibel Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aav strc gene transfer/product/Decibel Therapeutics
Average 90 stars, based on 1 article reviews
aav strc gene transfer - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Preclinical therapeutic pipeline for inner ear hearing disorders.

Journal: Biomedicines

Article Title: Recent Therapeutic Progress and Future Perspectives for the Treatment of Hearing Loss

doi: 10.3390/biomedicines11123347

Figure Lengend Snippet: Preclinical therapeutic pipeline for inner ear hearing disorders.

Article Snippet: Genetic ( STRC -mediated HL) , Gene therapy , AAV.104 , Undisclosed , Decibel Therapeutics (collaboration with Regeneron) , AAV STRC gene transfer to selectively target outer HCs.

Techniques: Formulation, Inhibition